Cargando…

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells

BACKGROUND: Cancer-associated fibroblasts and high mobility group box 1 (HMGB1) protein have been suggested to mediate cancer progression and chemotherapy resistance. The role of such fibroblasts in HMGB1 production in breast cancer is unclear. This study aimed to investigate the effects of cancer-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amornsupak, Kamolporn, Insawang, Tonkla, Thuwajit, Peti, O-Charoenrat, Pornchai, Eccles, Suzanne A, Thuwajit, Chanitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301465/ https://www.ncbi.nlm.nih.gov/pubmed/25512109 http://dx.doi.org/10.1186/1471-2407-14-955

Ejemplares similares

HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells
por: Amornsupak, Kamolporn, et al.
Publicado: (2022)

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
por: Oo, Khine Kyaw, et al.
Publicado: (2021)

The metabolic cross‐talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
por: Thuwajit, Chanitra, et al.
Publicado: (2017)

Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
por: Sumransub, Nuttavut, et al.
Publicado: (2020)

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer
por: Thongchot, Suyanee, et al.
Publicado: (2022)

Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines
por: Thongchot, Suyanee, et al.
Publicado: (2021)

Interleukin-8 released by cancer-associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells
por: Thongchot, Suyanee, et al.
Publicado: (2021)

Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)
por: Thongchot, Suyanee, et al.
Publicado: (2023)

Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
por: Singsuksawat, Ekapot, et al.
Publicado: (2018)

High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma
por: Yangngam, Supaporn, et al.
Publicado: (2020)

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
por: Utispan, Kusumawadee, et al.
Publicado: (2010)

Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer
por: Soongsathitanon, Jarupa, et al.
Publicado: (2021)

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
por: Chuangchot, Nisa, et al.
Publicado: (2023)

Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
por: Thongchot, Suyanee, et al.
Publicado: (2020)

Chronic Inflammation and Cytokines in the Tumor Microenvironment
por: Landskron, Glauben, et al.
Publicado: (2014)

Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis
por: Yangngam, Supaporn, et al.
Publicado: (2022)

Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
por: Sootichote, Rochanawan, et al.
Publicado: (2018)

DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma
por: Prachayakul, Varayu, et al.
Publicado: (2017)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
por: Utaijaratrasmi, Penkhae, et al.
Publicado: (2018)

Mesothelin-specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3-treated self-differentiated dendritic cells
por: Jirapongwattana, Niphat, et al.
Publicado: (2022)

Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma
por: Sonongbua, Jumaporn, et al.
Publicado: (2020)

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis
por: Thongchot, Suyanee, et al.
Publicado: (2022)

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
por: Thuwajit, Chanitra, et al.
Publicado: (2017)

Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors
por: Sawasdee, Nunghathai, et al.
Publicado: (2022)

Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein
por: Luangwattananun, Piriya, et al.
Publicado: (2022)

Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: A systematic review and meta-analysis
por: Numprasit, Warapan, et al.
Publicado: (2023)

Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells
por: Phannasil, Phatchariya, et al.
Publicado: (2015)

Response to Dr. Roger’s letter: further studies are necessary in order to conclude a causal association between the consumption of monosodium L-glutamate (MSG) and the prevalence of metabolic syndrome in the rural Thai population
por: Insawang, Tonkla, et al.
Publicado: (2013)

The Role of Vascular Endothelial Growth Factor A Polymorphisms in Breast Cancer
por: Sa-nguanraksa, Doonyapat, et al.
Publicado: (2012)

Gail Model Underestimates Breast Cancer Risk in Thai Population
por: Sa-Nguanraksa, Doonyapat, et al.
Publicado: (2019)

A Comparison Between the Online Prediction Models CancerMath and PREDICT as Prognostic Tools in Thai Breast Cancer Patients
por: Polchai, Nuanphan, et al.
Publicado: (2020)

The Evaluation of Magee Equation 2 in Predicting Response and Outcome in Hormone Receptor-Positive and HER2-Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Saigosoom, Napat, et al.
Publicado: (2020)

Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and Therapy
por: Plemmenos, Grigorios, et al.
Publicado: (2023)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome
por: Sa-nguanraksa, Doonyapat, et al.
Publicado: (2020)

The role of High Mobility Group Box 1 (HMGB1) in colorectal cancer
por: Süren, Dinç, et al.
Publicado: (2014)

High mobility group box-1 and its clinical value in breast cancer
por: Sun, Shanping, et al.
Publicado: (2015)

The dual role and therapeutic potential of high-mobility group box 1 in cancer
por: He, Si-Jia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b4ipgd2525213l9bgq20c0nhta